Alison L. Hannah insider trades

Open-market stock purchases and sales by Alison L. Hannah, EVP, Chief Medical Officer at Rigel Pharmaceuticals Inc, from SEC Form 4 filings since Jul 15, 2015.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +108%.

Recent trades

DateStockTradeValue
Jul 8, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
May 15, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—

Companies traded

  • RIGL Rigel Pharmaceuticals Inc: other filings, last Jul 8, 2026
  • NEO Neogenomics Inc: 2 buys, last Jun 1, 2025
  • CTMX CytomX Therapeutics, Inc: 1 sale, last Jul 20, 2022

Get free alerts when Alison L. Hannah files a new trade →